Legal Opinion

Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, Inc

Court of Appeals for the Federal Circuit

Decided October 20, 2014No. 2013-1306PublishedCited by 16 opinions

1Opinion of the Court

ON PETITION FOR PANEL REHEARING AND REHEARING EN BANC

2Per curiam

ORDER

A combined petition for panel rehearing and rehearing en banc was filed by plaintiff-appellant Bristol-Meyers Squibb Company, and a response thereto was invited by the court and filed by defendant-appellee Teva Pharmaceuticals USA, Inc. The petition for rehearing and response were referred to the panel that heard the appeal, and thereafter, the petition for rehearing en banc and response were referred to the circuit judges who are authorized to request a poll of whether to rehear the appeal en banc. A poll was requested, taken, and…

Also in this document: Concurrence.

3Cases cited4 opinions

  1. KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
  2. United States v. AdamsSupreme Court of the United States · 1966
  3. Genetics Institute, LLC v. Novartis Vaccines & Diagnostics, Inc.Court of Appeals for the Federal Circuit · 2011
  4. Ball & Socket Fastener Co. v. KraetzerSupreme Court of the United States · 1893

4Cited by16 opinions

  1. Ackley v. Rausch Coleman Development Group, Inc.District Court, W.D. Arkansas · 2019
  2. Ackley v. Rausch Coleman Development Group, Inc.District Court, W.D. Arkansas · 2019
  3. Brown v. Secretary of Health and Human ServicesUnited States Court of Federal Claims · 2020
  4. Burns v. Southern Glazer's IncDistrict Court, E.D. Arkansas · 2019
  5. Cottingham v. Secretary of Health and Human ServicesUnited States Court of Federal Claims · 2017

11 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API